Regal Rexnord (RRX) director gets 3.152 RSUs; holds 8,771.024
Regal Rexnord (RRX) reported an insider update showing a director acquired 3.152 additional restricted stock units on 10/14/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Regal Rexnord (RRX) reported an insider update showing a director acquired 3.152 additional restricted stock units on 10/14/2025. These units were credited under the dividend equivalent reinvestment provision following a quarterly dividend and are subject to the same vesting terms as the underlying awards.
After the transaction, the reporting person beneficially owned 8,771.024 shares on a direct basis. The filing lists a price of $143.14 for the acquisition entry.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3.152 | $143.14 | $451.18 |
Footnotes (1)
- F1. Represents additional restricted stock units credited to the reporting person under the dividend equivalent reinvestment provision of the reporting person's outstanding restricted stock unit awards as a result of a quarterly dividend payment. The additional restricted stock units resulting from the dividend equivalent reinvestment are subject to the same terms and conditions, including vesting, as the outstanding restricted stock unit awards to which they are attributable.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RRX disclose in this Form 4?
Why were additional RSUs credited to the RRX director?
Do the new RSUs have different terms?
How many securities does the reporting person own after the transaction?
What price is shown for the acquisition entry?
What is the insider’s relationship to RRX?
AI-generated analysis. How Rhea-AI works. Not financial advice.